Goldman Sachs analyst issues BUY recommendation for OXY on October 1, 2026 07:56AM ET. The previous analyst recommendation was Neutral.OXY was trading at $55.32 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 26 - Buy, 23 - Hold, 3 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
Vijay Rakesh from Mizuho Securities issued a price target of $1,400.00 for MU on 2026-10-01 07:02:00.The...
BMO Capital analyst issues OUTPERFORM recommendation for MU on October 1, 2026 07:09AM ET. The previous...
Wedbush analyst issues OUTPERFORM recommendation for MU on October 1, 2026 07:08AM ET. The previous analyst...
Raymond James analyst issues OUTPERFORM recommendation for MU on October 1, 2026 07:03AM ET. The previous...
Vijay Rakesh from Mizuho Securities issued a price target of $1,400.00 for MU on 2026-10-01 07:02:00.The adjusted price target was set to $1,400.00.At the time of the announcement, MU was...
Sam Margolin from Wells Fargo issued a price target of $57.00 for BP on 2026-09-30 21:45:24.The adjusted price target was set to $57.00.At the time of the announcement, BP was...
Aaron Rakers from Wells Fargo issued a price target of $63.00 for HPE on 2026-09-30 18:54:51.The adjusted price target was set to $63.00.At the time of the announcement, HPE was...
Atif Malik from Wolfe Research issued a price target of $1,300.00 for MU on 2026-09-30 16:04:08.The adjusted price target was set to $1,300.00.At the time of the announcement, MU was...
Robin Farley from UBS issued a price target of $36.00 for CCL on 2026-09-30 13:43:00.The adjusted price target was set to $36.00.At the time of the announcement, CCL was trading...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In a promising turn for Microsoft, the company continues to solidify its position in the market through its innovative Copilot offerings, which aim to integrate consumer and enterprise services more...
On Wednesday, Apple Inc. (NASDAQ:AAPL) experienced a noticeable surge in its stock, gaining 2%, following an optimistic forecast from Counterpoint Research. Analysts estimate that the tech giant could sell up...
Alphabet's Google is intensifying its battle against European Union regulations by requesting that an EU court temporarily halt an order requiring it to provide access to its extensive search data...
In a month filled with contrasting outcomes for leading automakers, Tesla Inc. (NASDAQ:TSLA) emerged as a notable victor in September, seeing its stock increase by approximately 1.1% to close at...
Financial markets are currently witnessing a seismic shift driven by advancements in artificial intelligence (AI), prompting notable figures such as Michael Burry—known for predicting past economic downturns—to voice concerns regarding...
